硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 NMNAT1 抗体对
试剂盒

人 NMNAT1 抗体对

01AB01885

Nicotinamide nucleotide adenylyltransferase 1 (NMNAT1) is a nuclear enzyme that catalyzes a crucial step in the biosynthesis of nicotinamide adenine dinucleotide (NAD+), converting nicotinamide mononucleotide (NMN) and ATP into NAD+ and pyrophosphate, a reaction essential for cellular metabolism and energy homeostasis. NMNAT1 exhibits transferase and nucleotidyltransferase activity, binding nucleotides and ATP, and is strongly inhibited by certain polyphenols such as gallotannin. The protein is highly conserved and plays a protective role in neuronal cells, notably delaying axonal degeneration after injury, although its axon-protective function is less robust than that of the related Wld(S) protein. Clinically, mutations in NMNAT1 are linked to Leber's congenital amaurosis type 9 (LCA9), a severe inherited retinal dystrophy that leads to early-onset vision loss. Additionally, NMNAT1 expression declines with age in several tissues, potentially impacting NAD+ metabolism and age-related cellular functions.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
NMNAT1
基因别名
NMNAT
蛋白别名
nicotinamide nucleotide adenylyltransferase 1; NMNAT1
UniProt
Q9HAN9
物种
Human

产品详情

靶点名称
NMNAT1
蛋白名称
nicotinamide nucleotide adenylyltransferase 1
蛋白别名
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1; NMN/NaMN adenylyltransferase 1; Nicotinamide-nucleotide adenylyltransferase 1; NMN adenylyltransferase 1; Nicotinate-nucleotide adenylyltransferase 1; NaMN adenylyltransferase 1
靶点基因名
NMNAT1
基因别名
NMNAT
UniProt
Q9HAN9
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Nicotinamide nucleotide adenylyltransferase 1 (NMNAT1) is a nuclear enzyme that catalyzes a crucial step in the biosynthesis of nicotinamide adenine dinucleotide (NAD+), converting nicotinamide mononucleotide (NMN) and ATP into NAD+ and pyrophosphate, a reaction essential for cellular metabolism and energy homeostasis. NMNAT1 exhibits transferase and nucleotidyltransferase activity, binding nucleotides and ATP, and is strongly inhibited by certain polyphenols such as gallotannin. The protein is highly conserved and plays a protective role in neuronal cells, notably delaying axonal degeneration after injury, although its axon-protective function is less robust than that of the related Wld(S) protein. Clinically, mutations in NMNAT1 are linked to Leber's congenital amaurosis type 9 (LCA9), a severe inherited retinal dystrophy that leads to early-onset vision loss. Additionally, NMNAT1 expression declines with age in several tissues, potentially impacting NAD+ metabolism and age-related cellular functions.